IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 19 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $604,000 | +152.7% | 106,220 | +23.2% | 0.00% | – |
| Q3 2018 | $239,000 | +30.6% | 86,246 | +3.9% | 0.00% | – |
| Q2 2018 | $183,000 | +39.7% | 83,032 | +11.2% | 0.00% | – |
| Q1 2018 | $131,000 | +3.1% | 74,694 | +0.1% | 0.00% | – |
| Q4 2017 | $127,000 | +10.4% | 74,638 | +4.8% | 0.00% | – |
| Q3 2017 | $115,000 | -49.3% | 71,194 | +0.5% | 0.00% | – |
| Q2 2017 | $227,000 | -3.0% | 70,865 | +26.0% | 0.00% | – |
| Q1 2017 | $234,000 | – | 56,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|